KR20160125563A - And method of manufacturing fruit mixture and maxture pharmacognosy - Google Patents
And method of manufacturing fruit mixture and maxture pharmacognosy Download PDFInfo
- Publication number
- KR20160125563A KR20160125563A KR1020150055808A KR20150055808A KR20160125563A KR 20160125563 A KR20160125563 A KR 20160125563A KR 1020150055808 A KR1020150055808 A KR 1020150055808A KR 20150055808 A KR20150055808 A KR 20150055808A KR 20160125563 A KR20160125563 A KR 20160125563A
- Authority
- KR
- South Korea
- Prior art keywords
- concentrate
- weight
- red ginseng
- mixture
- mixed
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 title abstract description 12
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 88
- 235000008504 concentrate Nutrition 0.000 claims abstract description 84
- 239000012141 concentrate Substances 0.000 claims abstract description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 19
- 239000008213 purified water Substances 0.000 claims abstract description 15
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 14
- 235000021028 berry Nutrition 0.000 claims abstract description 9
- 239000006188 syrup Substances 0.000 claims abstract description 9
- 235000020357 syrup Nutrition 0.000 claims abstract description 9
- 241001444063 Aronia Species 0.000 claims abstract description 8
- 240000001810 Angelica gigas Species 0.000 claims abstract description 5
- 235000018865 Angelica gigas Nutrition 0.000 claims abstract description 5
- 244000294611 Punica granatum Species 0.000 claims abstract 3
- 240000004246 Agave americana Species 0.000 claims abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 18
- 239000011259 mixed solution Substances 0.000 claims description 18
- 235000013361 beverage Nutrition 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 229960004543 anhydrous citric acid Drugs 0.000 claims description 8
- 239000001509 sodium citrate Substances 0.000 claims description 8
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 8
- 235000015197 apple juice Nutrition 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 5
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 235000013525 pomegranate juice Nutrition 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 241000609240 Ambelania acida Species 0.000 claims description 3
- 239000010905 bagasse Substances 0.000 claims description 3
- 239000011888 foil Substances 0.000 claims description 3
- 241000092897 Angelica japonica Species 0.000 claims description 2
- 229940107131 ginseng root Drugs 0.000 claims description 2
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 229940054534 ophthalmic solution Drugs 0.000 claims description 2
- 239000002997 ophthalmic solution Substances 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 241001593968 Vitis palmata Species 0.000 abstract description 11
- 241000208340 Araliaceae Species 0.000 abstract description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 9
- 235000008434 ginseng Nutrition 0.000 abstract description 9
- 239000007788 liquid Substances 0.000 abstract description 7
- 241000220225 Malus Species 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 208000007502 anemia Diseases 0.000 abstract description 4
- 238000001914 filtration Methods 0.000 abstract description 4
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000001256 tonic effect Effects 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 241001303775 Phlomis Species 0.000 abstract 1
- 230000009245 menopause Effects 0.000 abstract 1
- 230000005070 ripening Effects 0.000 abstract 1
- 241000219991 Lythraceae Species 0.000 description 11
- 244000193174 agave Species 0.000 description 7
- 230000032683 aging Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000020710 ginseng extract Nutrition 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241001474374 Blennius Species 0.000 description 3
- 206010027304 Menopausal symptoms Diseases 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 241000255791 Bombyx Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000005499 Sasa Species 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- -1 polyphenol compounds Chemical class 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- RWXIFXNRCLMQCD-CZIWJLDFSA-N (20R)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-CZIWJLDFSA-N 0.000 description 1
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- RDIMTXDFGHNINN-UHFFFAOYSA-N (3R,9R,10R)-1-heptadecen-4,6-diyne-3,9,10-triol Natural products CCCCCCCC(O)C(O)CC#CC#CC(O)C=C RDIMTXDFGHNINN-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 1
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- HXCGUCZXPFBNRD-DNLMCPORSA-N Nodakenin Chemical compound CC(C)([C@@H]1OC2=CC=3OC(=O)C=CC=3C=C2C1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HXCGUCZXPFBNRD-DNLMCPORSA-N 0.000 description 1
- HXCGUCZXPFBNRD-QVYYAULWSA-N Nodakenin Natural products O(C(C)(C)[C@@H]1Oc2c(cc3c(OC(=O)C=C3)c2)C1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HXCGUCZXPFBNRD-QVYYAULWSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 1
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- HXCGUCZXPFBNRD-UHFFFAOYSA-N nodakenine Natural products C1C2=CC=3C=CC(=O)OC=3C=C2OC1C(C)(C)OC1OC(CO)C(O)C(O)C1O HXCGUCZXPFBNRD-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- RDIMTXDFGHNINN-IKGGRYGDSA-N panaxytriol Chemical compound CCCCCCC[C@H](O)[C@@H](O)CC#CC#C[C@H](O)C=C RDIMTXDFGHNINN-IKGGRYGDSA-N 0.000 description 1
- ZCKMUKZQXWHXOF-UHFFFAOYSA-N panaxytriol Natural products CCC(C)C(C)C(C)C(C)C(C)C(O)C(O)CC#CC#CC(O)C=C ZCKMUKZQXWHXOF-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002207 thermal evaporation Methods 0.000 description 1
- 230000007888 toxin activity Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
Abstract
Description
The present invention relates to a red ginseng beverage comprising a fruit mixture and a crude drug mixture, and more particularly, to a red ginseng beverage containing a mixture of fruits such as apple, pomegranate, red grape, agave syrup and aronia berry, The present invention is directed to a method for manufacturing a red ginseng beverage by mixing the purified ginseng mixture with the purified water and heating the ginseng mixture by heating, aging, sterilization and filtration.
Generally, red ginseng refers to a pale yellow or light reddish brown ginseng that has been dried for 4 to 6 years and steamed with steam without peeling the ginseng.
The red ginseng promotes non-enzymatic browning reaction during the production process, so that a large amount of browning reaction products are formed. Among them, a large amount of antioxidant components such as maltol are produced, thereby contributing to the quality stability of red ginseng, It is known that 8 kinds of red ginseng-specific ingredients not contained in common ginseng such as Ginsenoside Rh2, Re3 and Panaxytriol are contained.
In particular, red ginseng has been known to have anticancer, cancer cell toxin activity inhibitor, platelet aggregation inhibitor, liver barrier inhibitor, hypoglycemic component, obesity inhibitor component, aging inhibitor component and heavy metal detoxifying component. A variety of studies and products related to health supplements have been developed.
Among the fruits, apple contains pectin and polyphenol compounds, it inhibits the colon cancer and is effective for constipation. It is effective for dieting, and can be effective for anticancer, whitening, anti-aging, and lowering of cholesterol level. Pomegranate is estrogen , Polyphenol, lycopene, anthocyanin, and tannin, which are effective for tonic action and prevention of prostate cancer. Red grapes contain flavonoids, polyphenols, and resveratrol to prevent thrombogenesis, prevent cancer, and prevent cholesterol Which is a useful fruit that can be controlled.
It is a perennial herbaceous plant which is composed of lecithin, oxymethylanthraquinone, fat, tannin, etc., and is used for the enhancement of the heart, excitement of central nervous system, intestinal motility, constipation, eczema, skin disease, It is a potent plant. It is a perennial plant of perennials. It is composed of coumarin (decursin, omvellipelon, nodakenin, decursinol, asopimpinelin, etc.), vitamin B12, folic acid, essential oil, It is a perennial plant of Lamiaceae. It is composed of flavonoids, glycosides, amino acids, steroids, essential oils, tannins and alkaloids. It has bone, ligament damage, analgesic action, , An aesthetic effect, and blood circulation.
As a method for producing a concentrated liquid containing sodium hypochlorite in conventional red ginseng, Patent No. 10-1086348 (a method for producing a concentrate for extracting herbal medicines containing sodium hypochlorite and red ginseng) and Korean Patent No. 10-0390874 (a liquid phase containing red ginseng concentrate as a main raw material A method of manufacturing a beverage) has been proposed as a prior art.
The first patent discloses a process for preparing a matured dried Sasa bulb by washing the Sasa bulb, heating the mixture at 85 캜 for 3 hours with steam, heating the mixture at 100 캜 for 5 hours with steam, and then drying the mixture. The mixed solution was mixed with water at a weight ratio of 1:10, and the mixture was continuously stirred at 100-115 ° C under a pressure of 1.5-2.0 kg / cm 2 for 8-9 hours. The filtrate was put into a concentrator, and the vacuum pressure of the concentrator was adjusted to 65 to 75 kg / cm < 2 > at 60-70 DEG C, and the total filtration Concentrating the solution to 60 wt% of the solution to prepare a condensed extract of the desalinate; The red ginseng bulb and water were mixed at a weight ratio of 1:10, and the mixture was extracted at 80-90 ° C for 24 hours under a pressure of 0.5-1.0 kg / cm 2. The extract was filtered using a filter paper having an eye size of 10 μm And the filtrate is put into a concentrator, the vacuum pressure is 65 to 75 kg / cm 2, the concentration temperature is 60-70 ° C, and the circulating cooling water of the concentrator is 60-60 wt% of the total filtrate using cooling water of 0-5 ° C To produce a red ginseng extract concentrate; The mixture of the above extract and the extract of red ginseng was mixed at a ratio of 1: 1 and packed in a tubular container to prepare a packaging process.
In the second patent, the red ginseng extract, the raw ginseng extract, the ginseng extract, the ginseng extract, the ginseng extract, the red ginseng extract, the red ginseng extract, the red ginseng extract, 5% by weight of Ganoderma liquorice, 5% by weight of Gugija gum, 5% by weight of Gumijiaek liquorice, 5% by weight of Bombyx mugwort, 5% by weight of Bombyx mugwort, 7% , 3% by weight of sulfuric acid liquid water and 3% by weight of water-containing liquid water were mixed, and 6.95% by weight of honey and 0.05% by weight of sodium metabisulfite were mixed to prepare a liquid beverage.
The first registered patent discloses a method of mixing and drying dried seaweed and water by heating and rinsing the seaweed through the first and second stages, mixing and heating the extracted red seaweed with water, And red ginseng extract are mixed at a ratio of 1: 1 and packed in a container. It can be seen that it is a health drink in which the extract of the red ginseng and the ginseng is simply mixed.
In the second patent, the concentrated solution was prepared using various kinds of herbal medicines including red ginseng in the red ginseng. Since the extraction temperature for extracting the red ginseng is close to 100 ° C, the useful substance contained in red ginseng is destroyed, And the proper temperature for extracting each herbal medicine containing sewage is different, and there is a problem that the taste, the quality and the effect are expressed differently by the concentration, the mixing ratio, the pressure and the like upon extraction.
Accordingly, the present invention has been made for the purpose of solving the above-mentioned conventional problems, and it is an object of the present invention to provide a red ginseng concentrate without breaking the effective ingredient of red ginseng, and a fruit mixture such as apple, pomegranate, red grape, (Apple, pomegranate, red grape, etc.) and the main ingredient of herbal medicine (Baek HwaSooo, Angelica gigantis, and genus) is added to the intrinsic component of red ginseng, Which is a health supplement that can protect the liver, alleviate anemia, and alleviate the symptoms of menopausal symptoms of women, and a method for producing the red ginseng beverage.
The present invention relates to a process for preparing red ginseng concentrate by heating and concentrating red ginseng roots and red ginseng at a mixing ratio of 7: 3 to prepare a red ginseng concentrate, which comprises the steps of concentrating the red ginseng concentrate, pomegranate concentrate, red grape concentrate, agave syrup, agar berry concentrate, The purified mixture was prepared by mixing 73.48% by weight of purified purified water, 12.15% by weight of fruit mixture, 10% by weight of red ginseng concentrate, 10% by weight of fructo-oligosaccharide 3% by weight of citric acid, 1.3% by weight of crude drug mixture, 0.03% by weight of anhydrous citric acid, 0.03% by weight of vitamin C and 0.01% by weight of sodium citrate.
Also, red ginseng mixed with red ginseng and red ginseng at a weight ratio of 7: 3 was mixed with purified water at a weight ratio of 1:10 and extracted at a temperature of 55-90 ° C for 48-72 hours. Then, Was concentrated under vacuum at a temperature of 55-90 ° C for 2 to 48 hours to obtain a red ginseng concentrate. The red apple concentrate was prepared by mixing 33 wt% of apple concentrate, 24.7 wt% of pomegranate concentrate, 24.3 wt% of red grape concentrate, 8.2 wt% of agave syrup, A fruit juice mixture was prepared by mixing 1 wt.%, Aronia barley concentrate 4.1 wt.%, Honey 0.8 wt.%, Soybean peptide 0.4 wt.% And ocher concentrate 0.4 wt.% To obtain 77 wt.% Of bagasse concentrate, 8% by weight of the concentrate was mixed to prepare a herbal mixture. Then, 10% by weight of the red ginseng concentrate, 12.15% by weight of the fruit mixture, and 1.3% by weight of the crude drug mixture were mixed together with 73.48% by weight of purified water in the blender, 3 wt%, anhydrous citric acid 0.03 wt%, and vitamin C 0.03 % And 0.01% by weight of sodium citrate are further mixed and blended. The mixed solution is heated at 65-85 ° C for 6-10 hours and aged. The warmed and aged mixed solution is sterilized at 90 ° C or higher for 1 hour, The sterilized mixed solution is filtered with a filter having a size of 25 탆. The filtered mixed solution is packed and sealed while maintaining the temperature at 90 캜 or higher, and the red ginseng concentrate is mixed with a fruit mixed solution and a crude drug mixed solution to prepare a red ginseng beverage.
Therefore, the present invention relates to a method for preparing a red ginseng concentrate, which comprises mixing a mixture of fruits, such as apple, pomegranate, red grape, agave syrup, and aronia berry, Is effective as a synergistic effect of antioxidant effect and an effect as a preservative tonic agent and protects liver, alleviates anemia, and alleviates women's menopausal symptoms without destroying the active ingredient of red ginseng .
The structure and operation of the present invention will be described in detail as follows.
Red ginseng concentrate, agave syrup, agar berry concentrate, aronia berry concentrate, honey, soybean peptides, and acetic acid concentrate were prepared by heating and concentrating red ginseng root and red ginseng at a mixing ratio of 7: The mixture was mixed to prepare a mixed fruit solution. The mixture was mixed with the bagasse concentrate, Angelica gigas concentrate, and the latex concentrate to prepare a crude drug mixture. Then, 73.48% by weight of purified water, 12.15% by weight of fruit mixture, 10% by weight of red ginseng concentrate, , A crude drug mixture solution (1.3 wt%), anhydrous citric acid (0.03 wt%), vitamin C (0.03 wt%), and sodium citrate (0.01 wt%).
Red ginseng mixed with red ginseng and red ginseng at a weight ratio of 7: 3 was mixed with purified water at a weight ratio of 1:10, and extracted at a temperature of 55-90 ° C for 48-72 hours. The extracted foil was separated, And concentrated under reduced pressure at -90 DEG C for 2-48 hours to prepare a red ginseng concentrate,
The concentrate of apple juice, the concentrate of apple juice, the concentrate of apple juice, the apple concentrate, the pomegranate concentrate, the pomegranate concentrate, the pomegranate juice concentrate, the pomegranate juice concentrate, 0.4% by weight of an ophthalmic solution was mixed to prepare a fruit mixture,
77% by weight of Baekhosa concentrate, 15% by weight of Angelica japonica concentrate, and 8% by weight of a rapid concentrate were mixed to prepare a crude drug mixture,
10% by weight of the red ginseng concentrated solution, 12.15% by weight of the fruit mixture solution and 1.3% by weight of the crude drug mixture were mixed with 73.48% by weight of purified water, and the mixture was mixed with 3% by weight of fructooligosaccharide, 0.03% by weight of anhydrous citric acid, 0.03% % And 0.01 wt% of sodium citrate were further mixed and blended,
The mixed solution is heated at 65-85 DEG C for 6-10 hours and aged,
The warmed and aged mixed solution was sterilized at 90 DEG C or higher for 1 hour,
The sterilized mixture was filtered through a filter of 25 mu m,
The filtered mixture is packed and sealed while maintaining the temperature at 90 ° C or higher, and the red ginseng concentrate is mixed with a fruit mixture and a crude drug mixture to prepare a red ginseng beverage.
In the present invention as described above, red ginseng mixed with red ginseng and red ginseng is aged with purified water and mixed with a mixture of fruits such as apple, pomegranate, red grapes, and white ginseng, The present invention provides red ginseng beverages and their manufacturing methods that have the effect of preventing aging, enhancing the effect of health ginseng, protecting the liver, alleviating anemia, and alleviating symptoms of women's menopausal symptoms in an enhanced state without destroying the active ingredient of red ginseng .
The present invention relates to a red ginseng concentrate, which is prepared by combining a fruit mixed solution and a crude drug mixture together with refined water, aging, sterilization, filtration and packaging.
The red ginseng concentrate was prepared by mixing red ginseng and red ginseng at a weight ratio of 7: 3 and mixing the red ginseng with purified water at a weight ratio of 1:10. The mixture was heated at 55-90 ° C for 48-72 hours And the extracted foil is separated.
The separated extract is extracted by vacuum-condensation at 55-90 [deg.] C for 2-48 hours.
If the temperature is lower than 55 ° C, the extraction of the red ginseng solution is undesirable. If the temperature is higher than 90 ° C, the effective ingredient contained in red ginseng is destroyed and the utility value of the red ginseng solution deteriorates.
The fruit mixture was used as a mixture of apple concentrate, pomegranate concentrate, red grape concentrate, agave syrup, agar concentrate, aronia berry concentrate, honey, soybean peptide and apple juice concentrate. The blend ratio was 33 wt% of apple concentrate, 24.7 , 0.4% by weight of soybean peptide, and 0.4% by weight of an agarose concentrate were mixed and used in an amount of 0.1% by weight, 24.3% by weight of red grape concentrate, 8.2% by weight of Agave syrup, 4.1% by weight of Agarwood concentrate, 4.1% by weight of Aronia barley concentrate, do.
The crude drug mixture was prepared by mixing three kinds of herbal medicines, Bacillus subtilis concentrate, Angelica gigas concentrate, and herbaceous concentrate, and mixing ratio thereof was 77 wt% of Baisho Sosho concentrate, 15 wt% of Angelica gigas concentrate and 8 wt% do.
A method of preparing a red ginseng beverage produced together with the above solution is as follows.
12.15% by weight of the fruit mixture and 1.3% by weight of the herbal mixture were mixed in 10% by weight of the extract of the red ginseng, and the mixture was mixed with 73.48% by weight of purified water in a blender. To the mixture was added 3% by weight of fructooligosaccharide, 0.03% by weight of anhydrous citric acid, 0.03% by weight of C and 0.01% by weight of sodium citrate are further mixed and blended.
When the mixing is completed, the mixture is aged at 65-85 DEG C for 6-10 hours.
When the warming and aging processes are completed, the mixed solution is sterilized at 90 ° C for 1 hour, the sterilized mixed solution is filtered through a filter of 25 μm, and the filtered mixed solution is packed while maintaining the temperature at 90 ° C. or higher.
The preferable mixing ratio of the red ginseng beverage is 73.48% by weight of purified water, 12.15% by weight of fruit mixture, 10% by weight of red ginseng extract, 3% by weight of fructooligosaccharide, 1.3% by weight of crude drug mixture, 0.03% by weight of anhydrous citric acid, 0.03% And 0.01% by weight of sodium citrate.
It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention as defined in the appended claims. And such changes are within the scope of the claims.
Claims (2)
The concentrate of apple juice, the concentrate of apple juice, the concentrate of apple juice, the apple concentrate, the pomegranate concentrate, the pomegranate concentrate, the pomegranate juice concentrate, the pomegranate juice concentrate, 0.4% by weight of an ophthalmic solution was mixed to prepare a fruit mixture,
77% by weight of Baekhosa concentrate, 15% by weight of Angelica japonica concentrate, and 8% by weight of a rapid concentrate were mixed to prepare a crude drug mixture,
10% by weight of the red ginseng concentrate, 12.15% by weight of the fruit mixture, and 1.3% by weight of the crude drug mixture were mixed together with 73.48% by weight of purified water. To the mixture were added 3% by weight of fructooligosaccharide, 0.03% by weight of anhydrous citric acid, 0.03% % And 0.01 wt% of sodium citrate were further mixed and blended,
The mixed solution is heated at 65-85 DEG C for 6-10 hours and aged,
The warmed and aged mixed solution was sterilized at 90 DEG C or higher for 1 hour,
The sterilized mixture was filtered through a filter of 25 mu m,
Wherein the filtered mixed solution is packed and sealed while being kept at 90 캜 or higher to prepare a red ginseng beverage by mixing a fruit mixed solution and a crude drug mixed solution into a red ginseng concentrated solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150055808A KR101737572B1 (en) | 2015-04-21 | 2015-04-21 | And method of manufacturing fruit mixture and maxture pharmacognosy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150055808A KR101737572B1 (en) | 2015-04-21 | 2015-04-21 | And method of manufacturing fruit mixture and maxture pharmacognosy |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160125563A true KR20160125563A (en) | 2016-11-01 |
KR101737572B1 KR101737572B1 (en) | 2017-05-19 |
Family
ID=57484698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150055808A KR101737572B1 (en) | 2015-04-21 | 2015-04-21 | And method of manufacturing fruit mixture and maxture pharmacognosy |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101737572B1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180075297A (en) * | 2016-12-26 | 2018-07-04 | 김준형 | Manufacture for beverage of red garlic and red onion |
KR20180076273A (en) * | 2016-12-27 | 2018-07-05 | 재단법인 베리앤바이오식품연구소 | Mixed beverage composition containing aronia and barley mash and manufacturing method the same |
KR101892725B1 (en) | 2017-12-11 | 2018-08-28 | 최병진 | BEVERAGE COMPOSITION CONTAINING Lycium barbarum L. AND RED GINSENG |
KR101960037B1 (en) * | 2018-11-19 | 2019-03-20 | 태웅식품 주식회사 | Method for producing stick type red ginseng product comprising red ginseng mixed concentrate |
KR101978094B1 (en) | 2018-08-21 | 2019-05-13 | 최병진 | Highly nutrotious beverage composition |
KR20190057249A (en) * | 2019-05-20 | 2019-05-28 | 재단법인 진안홍삼연구소 | Beverage including red ginseng and punica granatum |
KR20220135282A (en) * | 2021-03-29 | 2022-10-07 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing Korean red ginseng and grape juice |
KR20230068468A (en) * | 2021-11-10 | 2023-05-18 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing peach juice |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101103017B1 (en) * | 2011-03-29 | 2012-01-05 | 안성찬 | The manufacturing method of red ginseng drink and red ginseng drink manufactured by this |
KR101414768B1 (en) * | 2013-04-09 | 2014-07-03 | 금호제약 (주) | Manufacturing method for beverage using cucumber and cucumber beverage thereby |
-
2015
- 2015-04-21 KR KR1020150055808A patent/KR101737572B1/en active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180075297A (en) * | 2016-12-26 | 2018-07-04 | 김준형 | Manufacture for beverage of red garlic and red onion |
KR20180076273A (en) * | 2016-12-27 | 2018-07-05 | 재단법인 베리앤바이오식품연구소 | Mixed beverage composition containing aronia and barley mash and manufacturing method the same |
KR101892725B1 (en) | 2017-12-11 | 2018-08-28 | 최병진 | BEVERAGE COMPOSITION CONTAINING Lycium barbarum L. AND RED GINSENG |
KR101978094B1 (en) | 2018-08-21 | 2019-05-13 | 최병진 | Highly nutrotious beverage composition |
KR101960037B1 (en) * | 2018-11-19 | 2019-03-20 | 태웅식품 주식회사 | Method for producing stick type red ginseng product comprising red ginseng mixed concentrate |
KR20190057249A (en) * | 2019-05-20 | 2019-05-28 | 재단법인 진안홍삼연구소 | Beverage including red ginseng and punica granatum |
KR20220135282A (en) * | 2021-03-29 | 2022-10-07 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing Korean red ginseng and grape juice |
KR20230068468A (en) * | 2021-11-10 | 2023-05-18 | 영동대벤처식품 (주) | Manufacturing method of functional health drink containing peach juice |
Also Published As
Publication number | Publication date |
---|---|
KR101737572B1 (en) | 2017-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101737572B1 (en) | And method of manufacturing fruit mixture and maxture pharmacognosy | |
CN103749816B (en) | Lotus leaf bitter gourd lipid-lowering health-care tea and preparation method thereof | |
KR101612813B1 (en) | Manufacturing method of fermented salt containing ginseng steaed red juice | |
CN104287036B (en) | A kind of Chinese herbal medicine green tea health vinegar beverage and production technology | |
KR102448542B1 (en) | Composition for relieving menopausal symptom | |
CN103652203A (en) | Abelmoschus manihot medic tea bag and preparation method | |
KR20130098051A (en) | Composition comprising herbal extract of red ginseng, angelicae gigantis radix, citrus peel and green tea leaves for treating or preventing vascular diseases | |
US11564897B2 (en) | Method for producing a polyphenolic composition from barley malt | |
KR20110116409A (en) | Manufacturing method of herbal medicine vegetable juice for improvement of blood circulation herbal medicine vegetable juice for improvement of blood circulation manufactured by the same | |
CN102845748B (en) | Composition containing tea polyphenol and cordyceps militaris and preparation method thereof | |
CN103767011B (en) | A kind of plant beverage and preparation method thereof | |
KR101086348B1 (en) | process of manufacturing Korean medicine | |
KR20180058144A (en) | Sea buckthorn beverage and preparation method thereof | |
CN104770489A (en) | Composition having anti-oxidation function and preparation method thereof | |
KR101953576B1 (en) | Functional beverage for anticancer and process for preparing the same | |
KR101871452B1 (en) | The Opuntia humifusa beverages containing lotus root element method. | |
KR20140103668A (en) | Functional beverage contained manuka honey and red ginseng | |
KR100583435B1 (en) | Beverage composition containing ginseng for the prevention of happertension | |
CN107736523A (en) | A kind of black meal fruit beverage preparation technology | |
CN108841525A (en) | A kind of preparation method of green tea wine | |
KR20150062553A (en) | Manufacturing method of composition of health food containing Ixeris Dentata extracts and composition of health food containing Ixeris Dentata extracts manufactured by the same | |
CN102613349A (en) | Ginkgo garlic yellow tea composite particle drink | |
Asif | Phytochemical and ethnobotanical effect of Aloe vera | |
CN102630780A (en) | Gingko-garlic-black tea composite granular beverage | |
KR101209369B1 (en) | Preparation method of fraction of Adenophora remoti flora extract and inner beauty food comprising the fraction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |